New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics.
about
Computational characterisation of cancer molecular profiles derived using next generation sequencingImmunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseLaser capture microdissection technologyEmerging molecular markers of cancer.Clinical proteomics for cancer biomarker discovery and therapeutic targeting.Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry.Tagless extraction-retentate chromatography: a new global protein digestion strategy for monitoring differential protein expression.Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.In silico estimates of tissue components in surgical samples based on expression profiling data.Targeting phosphoprotein profiling by combination of hydroxyapatite-based phosphoprotein enrichment and SELDI-TOF MS.Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis.The knowledge-integrated network biomarkers discovery for major adverse cardiac eventsSystems analysis of EGF receptor signaling dynamics with microwestern arrays.Proteomic technology for biomarker profiling in cancer: an updateSELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis.The proteome: anno Domini 2002.Genomics and proteomics: implications for inflammatory bowel diseases.Nuclear receptors and the Warburg effect in cancer.Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.Targeted protein-omic methods are bridging the gap between proteomic and hypothesis-driven protein analysis approaches.Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis.Molecular aspects of prostate cancer: implications for future directions.A protein profile study to discriminate CIN lesions from normal cervical epithelium.Current Awareness on Comparative and Functional Genomics
P2860
Q28080523-95780C6F-4F1D-4143-B9CF-F16B221BE9BDQ28238379-FA72B392-540B-4051-A31D-31D91D14EB11Q28250373-F1085B4C-7679-4119-B2F8-6E4FE378EFC3Q30330271-D8C6CD72-3BA7-4ADA-811D-54C96F5841FCQ30893390-09274997-FE04-4C39-9E58-0116122C2931Q31111452-6EFD0354-CAB8-4F19-9B4D-E8C56E73E9A0Q31111488-9FDE2203-7D65-4324-BFEF-E648BA7506CCQ33304365-D222D374-8A20-4618-B256-E93478D99B8AQ33642598-D5F6CCE0-FD52-4434-86B7-C8BF02C561B4Q33667374-354B3837-7286-496C-BEE1-11C85527AF62Q33764377-49BF5DBD-2443-475A-9683-DD1831AE844FQ33789038-77E4F877-8FC0-499C-A349-A2BA6D8D9AADQ33896605-8D302979-E7B8-4DEA-9C33-0D246163F5B0Q34657835-D5C4E46A-7056-4B03-9AEF-28B6CACDEF7CQ35016599-2B226913-2D02-4DDE-857B-8B5253D2ACA6Q35127758-821DFD35-6897-4D7C-ACDF-99FB5F830732Q35787618-A8311995-DB9C-4665-8BF1-58D8542D7DFAQ36683880-F1530A84-AFF1-4918-94AB-ECFF0F37EB7BQ37790704-00984B06-D092-4B57-B4D2-F51E247B3384Q37945786-8B3C5250-BECD-4A79-BAB7-9732295E8668Q38821536-600467C0-D39C-4131-B6F9-A1AEF8589E18Q40441090-4C932432-0608-43E2-BE95-4C21E6EE5414Q55428476-11EB317D-3422-46B7-8F66-31663528B0DAQ56887724-4AF8B38E-8EFA-4E1D-95BC-003AC2C5A3B4
P2860
New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
New technologies for biomarker ...... section and tissue proteomics.
@ast
New technologies for biomarker ...... section and tissue proteomics.
@en
type
label
New technologies for biomarker ...... section and tissue proteomics.
@ast
New technologies for biomarker ...... section and tissue proteomics.
@en
prefLabel
New technologies for biomarker ...... section and tissue proteomics.
@ast
New technologies for biomarker ...... section and tissue proteomics.
@en
P2093
P1433
P1476
New technologies for biomarker ...... section and tissue proteomics.
@en
P2093
Paweletz CP
Petricoin EF 3rd
P304
P356
10.1016/S0090-4295(00)00964-X
P407
P433
P577
2001-04-01T00:00:00Z